Association of the (CA) n repeat polymorphism of insulin-like growth factor-I and -202 A/C IGF-binding protein-3 promoter polymorphism with adult height in patients with severe growth hormone deficiency

Clinical Endocrinology

Volumn 76, Issue 5, 2012, Pages 683-690

  Miletta, Maria Consolata ^a   Scheidegger, Ursina A ^a   Giordano, Mara ^b   Bozzola, Mauro ^c   Pagani, Sara ^c   Bona, Gianni ^b   Dattani, Mehul ^d   Hindmarsh, Peter C ^d   Petkovic, Vibor ^a   Oser Meier, Monika ^a   Flück, Christa E ^a   Mullis, Primus E ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; RECOMBINANT GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; ALLELE; ARTICLE; BODY HEIGHT; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; GROWTH HORMONE DEFICIENCY; GROWTH RETARDATION; HORMONAL THERAPY; HORMONE DETERMINATION; HUMAN; IMMUNORADIOMETRIC ASSAY; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; TREATMENT RESPONSE;

ADULT; AGED; BODY HEIGHT; CHILD; CHILD, PRESCHOOL; DINUCLEOTIDE REPEATS; FEMALE; GENE FREQUENCY; GENOTYPE; GROWTH DISORDERS; HORMONE REPLACEMENT THERAPY; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHENOTYPE; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84859649797     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2011.04267.x     Document Type: Article

References (39)

1. Ranke, M.B. (2010) Clinical considerations in using growth hormone therapy in growth hormone deficiency. Endocrine Development 18, 83-91.
2. Ranke, M.B., Lindberg, A., Chatelain, P. et al. (1999) Derivation and validation of a mathematical model for predicting the response to exogenous recombinant human growth hormone (GH) in prepubertal children with idiopathic GH deficiency. KIGS International Board. Kabi Pharmacia International Growth Study. Journal of Clinical Endocrinology and Metabolism 84, 1174-1183. (Pubitemid 30644371)
3. Geffner, M.E. & Dunger, D.B. (2007) Future directions: growth prediction models. Hormone Research 68(Suppl. 5), 51-56.
4. Raz, B., Janner, M., Petkovic, V. et al. (2008) Influence of growth hormone (GH) receptor deletion of exon 3 and full-length isoforms on GH response and final height in patients with severe GH deficiency. Journal of Clinical Endocrinology and Metabolism 93, 974-980. (Pubitemid 351398582)
5. Wassenaar, M.J., Biermasz, N.R., Pereira, A.M. et al. (2009) The exon-3 deleted growth hormone receptor polymorphism predisposes to long-term complications of acromegaly. Journal of Clinical Endocrinology and Metabolism 94, 4671-4678.
6. Rosen, C.J., Kurland, E.S., Vereault, D. et al. (1998) Association between serum insulin growth factor-I (IGF-I) and a simple sequence repeat in IGF-I gene: implications for genetic studies of bone mineral density. Journal of Clinical Endocrinology and Metabolism 83, 2286-2290. (Pubitemid 28503015)
7. Rietveld, I., Janssen, J.A., van Rossum, E.F. et al. (2004) A polymorphic CA repeat in the IGF-I gene is associated with genderspecific differences in body height, but has no effect on the secular trend in body height. Clinical Endocrinology (Oxford 61, 195-203.
8. Vaessen, N., Janssen, J.A., Heutink, P. et al. (2002) Association between genetic variation in the gene for insulin-like growth factor- I and low birthweight. Lancet 359, 1036-1037. (Pubitemid 34286545)
9. Vaessen, N., Heutink, P., Janssen, J.A. et al. (2001) A polymorphism in the gene for IGF-I: functional properties and risk for type 2 diabetes and myocardial infarction. Diabetes 50, 637-642. (Pubitemid 32195230)
10. Frayling, T.M., Hattersley, A.T., McCarthy, A. et al. (2002) A putative functional polymorphism in the IGF-I gene: association studies with type 2 diabetes, adult height, glucose tolerance, and fetal growth in U.K. populations. Diabetes 51, 2313-2316. (Pubitemid 34729041)
11. Rasmussen, S.K., Lautier, C., Hansen, L. et al. (2000) Studies of the variability of the genes encoding the insulin-like growth factor I receptor and its ligand in relation to type 2 diabetes mellitus. Journal of Clinical Endocrinology and Metabolism 85, 1606-1610. (Pubitemid 32293561)
12. Schut, A.F., Janssen, J.A., Deinum, J. et al. (2003) Polymorphism in the promoter region of the insulin-like growth factor I gene is related to carotid intima-media thickness and aortic pulse wave velocity in subjects with hypertension. Stroke 34, 1623-1627. (Pubitemid 36842614)
13. Rietveld, I., Janssen, J.A., Hofman, A. et al. (2003) A polymorphism in the IGF-I gene influences the age-related decline in circulating total IGF-I levels. European Journal of Endocrinology 148, 171-175. (Pubitemid 36305683)
14. Rietveld, I., Janssen, J.A., Van Duijn, C.M. et al. (2003) A polymorphic CA repeat in the promoter region of the insulin-like growth factor-I (IGF-I) gene. European Journal of Epidemiology 18, 191-193. (Pubitemid 36597135)
15. Deal, C., Ma, J., Wilkin, F. et al. (2001) Novel promoter polymorphism in insulin-like growth factor-binding protein-3: correlation with serum levels and interaction with known regulators. Journal of Clinical Endocrinology and Metabolism 86, 1274-1280. (Pubitemid 32323016)
16. Schernhammer, E.S., Hankinson, S.E., Hunter, D.J. et al. (2003) Polymorphic variation at the -202 locus in IGFBP3: Influence on serum levels of insulin-like growth factors, interaction with plasma retinol and vitamin D and breast cancer risk. International Journal of Cancer 107, 60-64. (Pubitemid 37100086)
17. Al-Zahrani, A., Sandhu, M.S., Luben, R.N. et al. (2006) IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer. Human Molecular Genetics 15, 1-10. (Pubitemid 43020099)
18. Prader, A., Largo, R.H., Molinari, L. et al. (1989) Physical growth of Swiss children from birth to 20 years of age. Helvetica Paediatrica Acta 52(Suppl.), 1-125.
19. Brook, C.G. (1993) A Guide to the Practice of Paediatric Endocrinology. University Press, Cambridge.
20. Ranke, M.B. (2003) Diagnosis of Growth Hormone Deficiency and Growth Hormone Stimulation Tests (In Diagnosis of Endocrine Function in Children and Adolescents). Krager, Basel.
21. Marshall, W.A. & Tanner, J.M. (1970) Variations in pattern of pubertal changes in boys. Archives of Disease in Childhood 45, 15-23.
22. Greulich, W.W. & Pyle, S.I. (1959) Radiographic Atals of Skeletal Development of the Hand and Wrist. Standford University Press, Standford.
23. Tanner, J.M., Whitehouse, R.H., Marshall, W.A. et al. (1975) Prediction of adult height from height, bone age, and occurrence of menarche, at ages 4 to 16 with allowance for midparent height. Archives of Disease in Childhood 50, 14-26.
24. Mullis, P.E., Robinson, I.C., Salemi, S. et al. (2005) Isolated autosomal dominant growth hormone deficiency: an evolving pituitary deficit? A multicenter follow-up study Journal of Clinical Endocrinology and Metabolism 90, 2089-2096. (Pubitemid 40586244)
25. Blum, W.F., Albertsson-Wikland, K., Rosberg, S. et al. (1993) Serum levels of insulin-like growth factor I (IGF-I) and IGF binding protein 3 reflect spontaneous growth hormone secretion. Journal of Clinical Endocrinology and Metabolism 76, 1610-1616. (Pubitemid 23164387)
26. Mullis, P.E., Akinci, A., Kanaka, C. et al. (1992) Prevalence of human growth hormone-1 gene deletions among patients with isolated growth hormone deficiency from different populations. Pediatric Research 31, 532-534.
27. Chen, E.Y., Liao, Y.C., Smith, D.H. et al. (1989) The human growth hormone locus: nucleotide sequence, biology, and evolution. Genomics 4, 479-497.
28. Wagner, J.K., Eble, A., Cogan, J.D. et al. (1997) Allelic variations in the human growth hormone-1 gene promoter of growth hormonedeficient patients and normal controls. European Journal of Endocrinology 137, 474-481. (Pubitemid 27505306)
29. Akin, F., Turgut, S., Cirak, B. et al. (2010) IGF(CA)19 and IGFBP- 3-202A/C gene polymorphism in patients with acromegaly. Growth Hormone and IGF Research 20, 399-403.
30. Raben, M.S. (1958) Treatment of a pituitary dwarf with human growth hormone. Journal of Clinical Endocrinology and Metabolism 18, 901-903.
31. Ranke, M.B. & Lindberg, A. (2010) Observed and predicted growth responses in prepubertal children with growth disorders: guidance of growth hormone treatment by empirical variables. Journal of Clinical Endocrinology and Metabolism 95, 1229-1237.
32. Bakker, B., Frane, J., Anhalt, H. et al. (2008) Height velocity targets from the national cooperative growth study for first-year growth hormone responses in short children. Journal of Clinical Endocrinology and Metabolism 93, 352-357. (Pubitemid 351240802)
33. Rosenfeld, R.G. (2006) Editorial: the pharmacogenomics of human growth. Journal of Clinical Endocrinology and Metabolism 91, 795-796.
34. Ranke, M.B., Savage, M.O., Chatelain, P.G. et al. (1999) Long-term treatment of growth hormone insensitivity syndrome with IGF-I. Results of the European multicentre study. The working group on growth hormone insensitivity syndromes. Hormone Research 51, 128-134. (Pubitemid 29389370)
35. Blethen, S.L., Baptista, J., Kuntze, J. et al. (1997) Adult height in growth hormone (GH)-deficient children treated with biosynthetic GH. The Genentech Growth Study Group. Journal of Clinical Endocrinology and Metabolism 82, 418-420. (Pubitemid 27068604)
36. Mullis, P.E. (2011) Genetics of GHRH, GHRH-receptor, GH and GH-receptor: its impact on pharmacogenetics. Baillieres Best Pract Res Clin Endocrinol Metab 25, 25-41.
37. Wassenaar, M.J., Dekkers, O.M., Pereira, A.M. et al. (2009) Impact of the exon 3-deleted growth hormone (GH) receptor polymorphism on baseline height and the growth response to recombinant human GH therapy in GH-deficient (GHD) and non-GHD children with short stature: a systematic review and meta-analysis. Journal of Clinical Endocrinology and Metabolism 94, 3721-3730.
38. Estany, J., Tor, M., Villalba, D. et al. (2007) Association of CA repeat polymorphism at intron 1 of insulin-like growth factor (IGF-I) gene with circulating IGF-I concentration, growth, and fatness in swine. Physiological Genomics 31, 236-243. (Pubitemid 350014401)
39. Costalonga, E.F., Antonini, S.R., Guerra-Junior, G. et al. (2009) The -s202 A allele of insulin-like growth factor binding protein-3 (IGFBP3) promoter polymorphism is associated with higher IGFBP- 3 serum levels and better growth response to growth hormone treatment in patients with severe growth hormone deficiency. Journal of Clinical Endocrinology and Metabolism 94, 588-595.